Science Speaks is at IDWeek in San Diego, California this week, bringing live coverage of sessions on HIV, TB, Ebola and more. SAN DIEGO, Calif – Despite steady progress made against the HIV pandemic over the past decade, only one third of people living with HIV are on antiretroviral therapy, leaving over 23 million people in need […]
Science Speaks is at IDWeek in San Diego, California this week, bringing live coverage of sessions on HIV, TB, Ebola and more. SAN DIEGO, Calif. – After the HPTN 052 trial settled the question of whether early HIV treatment prevents transmission of the virus, the START trial settled the question of the value of treatment for individual health, Dr. Myron Cohen […]
HIV
Progress seen in recent years against the HIV pandemic, including in rising numbers of people diagnosed and treated accompanied by dropping rates of incidence and death, […]
Tuberculosis
SYDNEY – When Merinda Sebayang was undergoing treatment for multidrug-resistant TB in Indonesia – a nation with the third highest tuberculosis burden in the world after […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]